|Market Cap (Intraday)||362.58M|
|2yr Forward PE||N/A|
XOMA Corp Stock, NASDAQ:XOMA
XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.